← SynDRA
CAMICINAL
SynDRA canonical compound SYN0011925 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MLNR |
|---|
| Mechanism of action | Motilin receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Motilin receptor agonist
- MLNR AGONIST
- MLNR FULL AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- GHSR
- HDAC6
- KCNH2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- GSK962040
- GSK-962040
- GSK-962040B
- GSK962040B
- 3C8348951H
- camicinalum
- RefChem:573678
- Camicinal free base
- Camicinal [USAN:INN]
- UNII-3C8348951H
- GSK962040 hydrochloride
- CAMICINAL [INN]
- Camicinal (USAN/INN)
- CAMICINAL [USAN]
- CAMICINAL [WHO-DD]
- C25H33FN4O
- GTPL4035
- orb1709517
- SCHEMBL1704099
- CHEBI:177624
- GLXC-15745
- BDBM50292978
- AKOS030527001
- NCGC00378581-01
- DA-53764
- FG103447
- HY-10922
- MS-27473
- NS00072114
- D10330
- F85006
- T11508
- BRD-K23248433-001-01-8
- GSK 962040
- Каміцинал
- PD102483
- C25H34ClFN4O
- MS-28466
Look up CAMICINAL in the interactive SynDRA portal →